X
skip to main content
Logo
  • February 15, 2017

    New Brunswick-led national research team aims for tailored treatments for patients with incurable multiple myeloma through Terry Fox Research Institute's $5-million investment.

  • February 15, 2017

    In the House of Commons today, Cambridge MP Bryan May congratulated TFRI and its joint pilot project partners -- The Princess Margaret Cancer Centre and the BC Cancer Agency -- for their new partnership to accelerate precision medicine. You can listen to his remarks on You Tube. or read them below.

  • February 02, 2017

    The Terry Fox Research Institute and two leading cancer centres in Canada -- the Princess Margaret Cancer Centre and the BC Cancer Agency -- have launched an innovative pilot project to accelerate precision medicine for their cancer patients.

  • January 04, 2017

    A biomarker study by COEUR (Canadian Ovarian Experimental Unified Resource), TFRI’s pan-Canadian ovarian cancer research team, examining over 2,000 ovarian cancer tissue samples has led to the development of an inexpensive immunohistochemical algorithm for classifying the five different disease subtypes.

  • January 04, 2017

    Awards to three New Investigators were made by TFRI in late December 2016, for a total investment of $1.3 million. Each award is valued at $450,000 for a term of three years, commencing Jan. 1, 2017. Recipients are: Dr. Housheng Hansen He (UHN), Dr. Frédérick Mallette (UdeM), and Dr. Peter Stirling (BC Cancer Agency).

  • January 03, 2017

  • January 03, 2017

  • January 03, 2017

  • January 03, 2017

  • January 03, 2017

  • December 14, 2016

    Follicular lymphoma (FL), the second most common form of non-Hodgkin lymphoma, is a largely incurable disease of B cells, yet in many cases, because of its indolent nature, survival can extend to well beyond 10 years following diagnosis. Yet in a small number of cases, histological transformation - where fast-growing cells outnumber the smaller, slow-growing cells - or early progression to aggressive lymphoma occurs.

  • December 08, 2016

    TORONTO, Canada – Dec. 7, 2016 – Leukemia researchers at Princess Margaret Cancer Centre, with funding from Terry Fox and others, have developed a 17-gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard treatment.

  • December 08, 2016

    TFRI's Ontario Node Research Symposium held on Monday, December 5 in Toronto drew over 400 people this year from across the province and beyond to hear a variety of interesting talks on the theme of Innovating Towards Transformative Cancer Care.

  • November 16, 2016

    TFRI's office in Vancouver, BC welcomed some special guests last month with the visit of three children from the Grade 1 class at St. John's School. The trio, along with a parent and a caregiver, were here to visit with Darrell Fox, Terry's younger brother, who shared with them books and stories about Terry.

  • September 29, 2016

    TFRI-funded research teams from coast to coast showed their true colours this year, turning out by the dozens in researcher-designated purple T-shirts and forming teams to raise funds for cancer research at the 36th Terry Fox Run on Sunday Sept. 18. Early estimates show the research community's fundraising efforts resulted in over $105,000 raised.

Back to Top